Dividend Assets Capital, LLC Novartis Ag Transaction History

Dividend Assets Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$92.52 - $104.91 $13,878 - $15,736	-150 Reduced 17.5%	707 $71,000
Q2 2021 Jul 23, 2021	SELL	$85.24 - $94.15 $2,131 - $2,353	-25 Reduced 2.83%	857 $78,000
Q4 2020 Jan 22, 2021	BUY	$78.07 - $94.43 $68,857 - $83,287	882 New	882 $83,000
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $186,416 - $213,221	-2,475 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $267,017 - $297,322	-3,625 Reduced 59.43%	2,475 $212,000
Q3 2018 Nov 05, 2018	SELL	$66.94 - $77.43 $236,298 - $273,327	-3,530 Reduced 36.66%	6,100 $526,000
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $9,736 - $11,004	150 Added 1.58%	9,630 $727,000
Q1 2018 May 02, 2018	BUY	$70.39 - $84.15 $35,195 - $42,075	500 Added 5.57%	9,480 $766,000
Q4 2017 Jan 31, 2018	SELL	$72.33 - $77.64 $1,808 - $1,941	-25 Reduced 0.28%	8,980 $753,000
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $667,630 - $695,816	9,005	9,005 $773,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.